14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 2nd May 2024 CHRS stock ended at $2.17. This is 5.34% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 6.90% from a day low at $2.03 to a day high of $2.17.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Jun 17, 2020 $17.22 $17.56 $17.00 $17.12 1 294 294
Jun 16, 2020 $17.13 $17.44 $16.62 $17.17 1 058 196
Jun 15, 2020 $15.76 $16.76 $15.57 $16.69 1 114 581
Jun 12, 2020 $16.57 $16.59 $15.57 $16.08 1 711 644
Jun 11, 2020 $17.20 $17.23 $16.02 $16.14 1 806 825
Jun 10, 2020 $18.66 $18.85 $17.95 $17.97 876 308
Jun 09, 2020 $18.70 $19.06 $18.34 $18.56 1 137 467
Jun 08, 2020 $18.90 $18.92 $18.21 $18.80 1 058 687
Jun 05, 2020 $19.19 $19.63 $18.76 $18.82 1 080 767
Jun 04, 2020 $18.72 $19.27 $18.54 $18.74 1 081 724
Jun 03, 2020 $19.10 $19.65 $18.81 $18.86 1 110 452
Jun 02, 2020 $18.88 $19.28 $18.13 $19.16 1 469 262
Jun 01, 2020 $18.64 $19.00 $18.18 $18.67 1 437 527
May 29, 2020 $18.18 $18.94 $17.99 $18.64 14 074 858
May 28, 2020 $19.22 $19.49 $17.70 $18.25 3 408 079
May 27, 2020 $18.29 $19.72 $18.29 $19.15 6 038 489
May 26, 2020 $17.72 $17.72 $16.90 $16.96 1 356 404
May 22, 2020 $16.16 $17.14 $16.15 $17.09 793 817
May 21, 2020 $17.14 $17.45 $15.93 $16.25 1 131 337
May 20, 2020 $17.19 $17.82 $16.93 $17.24 955 562
May 19, 2020 $16.72 $17.21 $16.45 $16.82 1 972 706
May 18, 2020 $17.17 $17.28 $16.44 $16.86 2 474 977
May 15, 2020 $16.37 $16.99 $16.20 $16.62 1 028 290
May 14, 2020 $16.13 $16.57 $15.78 $16.43 863 351
May 13, 2020 $16.93 $17.43 $16.08 $16.38 935 766
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT